Liminatus Pharma, Inc. (LIMN)

Liminatus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	May 14, 2025	Dec 31, 2023	Dec 31, 2022
Last Close Price	6.57	10.33	10.12
Debt / Equity Ratio	-1.01	-1.02	-1.53
Quick Ratio	0.00	0.03	0.29
Current Ratio	0.19	0.12	0.39
Return on Assets (ROA)	-	-66.30%	-
Return on Capital (ROIC)	-	-101.31%	-
Buyback Yield / Dilution	-	-188.25%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.